US Edition
News from Clinical Trials Arena
If you want to know if Clinical Trials Arena is credible or reliable, look no further. We rank Clinical Trials Arena as Unknown factuality. Find out more about our methodology here.
Information about Clinical Trials Arena
Where is Clinical Trials Arena located?Clinical Trials Arena's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Clinical Trials Arena News
Stock Markets · United StatesCapricor Therapeutics, Inc. (NASDAQ:CAPR) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate, deramiocel.
CAPR stock is soaring. See the real-time price action here. The data release and stock surge triggered a dramatic response from controversial former pharma executive and prominent short-seller Martin Shkreli, who had publicly bet against Capricor's …See the Story
Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say - Capricor Therapeutics (NASDAQ:CAPR)
75% Center coverage: 4 sources
